Current stock page

Stock Analysis

Penumbra, Inc. (PEN) Stock Analysis

Penumbra, Inc. (PEN) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

PEN Stock Analysis Summary

Penumbra, Inc. (PEN) currently has an AIQ Score of 66/100, indicating a bullish setup. Risk is the strongest factor at 92/100. Value is the weakest current factor at 48/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data

PEN at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$320.60
AIQ Score66/100
Overall ViewBullish
Technical Analysis ConsensusNeutral
Market Cap$12.64B
P/E Ratio (TTM)79.98
Forward P/E—
EPS (Q3 FY2026)$1.07
Revenue (Q3 FY2026)$410.15M
Dividend Yield (TTM)0.00%
Beta0.19
Volume214.39K
52-week range$274.20-$362.41
RSI 1449.51
50-Day SMA$320.15
200-Day SMA$325.71
Analyst Price Target—
Next EarningsFeb 24, 2027
As of Nov 18, 2026 · Market close

PENPenumbra, Inc.

Healthcare / Medical - Devices

Leader

Strong Relative Position

BullishEdge 8/10
$320.60+$1.49 (+0.47%)

Latest quote

  • Momentum
    56
  • Value
    48
  • Quality
    78
  • Risk resilience
    92
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

PEN Stock Analysis Summary

Penumbra, Inc. (PEN) currently has an AIQ Score of 66/100, indicating a bullish setup. Risk resilience is the strongest factor at 92/100. Value is the weakest current factor at 48/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data
AIQ Composite Posture: Bullish

In a bullish regime, PEN has AIQ Score of 66/100 with Risk resilience base of 92/100 and fading Value at 48/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Risk resilience (92/100) leads while Value (48/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 0.47% stock move · PEN classified in Medical - Devices.

Current Evidence

BullishPEN is in a bullish AIQ regime; Risk resilience is the strongest visible factor at 92/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is PEN Bullish or Bearish Right Now?

PEN currently has a bullish overall setup. Risk Resilience is the strongest factor at 92/100, while Value is weakest at 48/100. The current evidence suggests a constructive setup.

Bull Case
  • - Quality is supportive at 78/100.
  • - Risk Resilience is supportive at 92/100.
  • - Price is +0.24% above its 50-day SMA.
Bear Case
  • - Value is the current constraint at 48/100.
  • - Price is -1.47% below its 200-day SMA.
  • - Technical consensus has more sell votes than buy votes (12 vs 11).

Current Consensus

PEN's Technical Analysis Consensus is currently Neutral, with 11 buy, 23 neutral, and 12 sell votes. PEN's 14-day RSI is 49.51, which places the stock in a neutral momentum range. PEN's beta is 0.19, indicating lower market sensitivity than the broad market.

Signal Confidence
Moderate agreement

What Changed in PEN?

The largest recent change in PEN is AIQ Score moving up by 0.0 points over the available 7-day comparison window. Risk Resilience remains the strongest visible factor.

AIQ Score
+0.0
Momentum
+0.0
Quality
+0.0
Risk
+0.0

What Would Change the PEN Outlook?

The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

PEN Decision Framework

Public evidence layers, setup checks, and risk context for Penumbra, Inc..

Penumbra, Inc. (PEN) Stock Analysis

Penumbra, Inc. has an AIQ Score of 66/100 in a Bullish regime. Risk is strongest at 92/100. Beta is 0.19, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextPEN is in a Bullish AIQ regime with score 66/100.
Signal ConflictThe primary conflict is that risk leads at 92/100 while value lags at 48/100.
Factor EvidenceMomentum 56/100 · Value 48/100 · Quality 78/100 · Risk 92/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Risk is the strongest factor at 92/100.

TimingWait

Momentum is 56/100 and RSI (14) is 49.5.

Regime fitPass

PEN is in a Bullish regime at 66/100.

Risk controlPass

Risk factor is 92/100 with beta 0.19 and annual volatility 19.46%.

ConflictWait

Current conflict: risk leads at 92/100 while value lags at 48/100.

AIQ Score
66/100
Price
$320.60
Beta
0.19
RSI (14)
49.5

PEN Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

PEN Fundamentals

PEN valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$410.15M
Net income
$42.28M
Free cash flow
$26.4M
View full PEN fundamental analysis

PEN Technical Analysis

PEN technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Neutral
RSI 14
49.51
Price vs SMA-50
+0.24%
View full PEN technical analysis

PEN Stock Catalysts

Track PEN earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Feb 24, 2027
Analyst target
—
News items
2
View PEN earnings and stock catalysts

PEN Dividend Analysis

PEN dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View PEN dividend history and analysis

PEN Financial Data

PEN revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$410.15M
EPS
$1.07
Periods
8
View PEN financials

PEN Risk Analysis

PEN volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.19
Risk score
92/100
1Y volatility
19.46%
View PEN risk analysis

PEN Stock News

PEN stock news, market tone, recent headlines, and catalyst context.

News items
2
Updated
Nov 18, 2026
Sentiment
—
Read PEN stock news

PEN vs Medical - Devices Peers

Current peer cohort: PEN · PHG · PRCT · SNN · TNDM. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
PEN
Current stock
66/10048/10056/10092/1000.6219.46%Current
PHG
Koninklijke Philips N.V.
72/10080/10072/10073/1000.1829.69%PEN vs PHG
PRCT
PROCEPT BioRobotics Corporation
49/10038/10060/10045/100-0.1165.89%PEN vs PRCT
SNN
Smith & Nephew plc
70/10079/10060/10075/100-0.227.30%PEN vs SNN
TNDM
Tandem Diabetes Care, Inc.
55/10064/10059/10038/1000.4975.74%PEN vs TNDM
Pairwise Compare links: PHG · PRCT · SNN · TNDMPEN vs PHGPEN vs PRCTPEN vs SNNPEN vs TNDMCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 18, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a PEN stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for PEN: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 19, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
79.98
As of Nov 18, 2026
Revenue growth
15.64%
Gross margin
67.98%
Current debt / equity
0.13
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$410.15M
Quarter net income
$42.28M
Quarter free cash flow
$26.4M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Mixed
Momentum
Mixed
RSI 14
49.51
MACD
0.09

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
92/100
Beta
0.19
Annual volatility
19.46%
Max drawdown
-12.23%

PEN Stock FAQ

What is PEN stock price today?

Penumbra, Inc.'s current stock price is $320.60. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is PEN bullish or bearish right now?

PEN's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is PEN's market cap?

PEN's market cap is $12.64B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is PEN's current P/E ratio?

PEN's current P/E ratio is 79.98 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is PEN's RSI?

PEN's 14-day RSI is 49.51 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is PEN above its 50-day and 200-day moving averages?

PEN is 0.24% from its 50-day SMA and -1.47% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is PEN's next earnings date?

PEN's next earnings date is currently listed as Feb 24, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does PEN pay a dividend?

PEN's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.